To assess the reliability of a biomimetic osteochondral scaffold Maioregen (Finceramica Faenza SpA, Faenza, Italt) as a salvage and joint-preserving procedure in the treatment of late stages of osteonecrosis of the knee. Nine active patients aged under 65 year presenting with clinical and radiological signs of SPONK were treated with a biomimetic osteochondral scaffold. All patients were clinically evaluated preoperatively and yearly with a minimum follow-up of 2 years. Subjective IKDC and Lysholm Knee Scale were used to assess clinical outcome. Pre-operative and post-operative pain was quantified with VAS scale. Activity level were evaluated pre-operatively and at follow-up according to Tegner Activity Scale.Purpose
Methods
To describe a 10-year long history of recurrent displacement and infection in a 37 yo female patient, HIV+/HCV+, with an history of drug addiction. Starting from avascular necrosis of the hip (caused by prolonged HAART therapy), the patient underwent first uncemented THA in 2003. One month after implant a septic mobilization due to local abscess was treated with first two stage revision surgery (modular stem with use of retention liner for intraoperatory instability and dislocation of the implant) that lasted for almost 6 years. After 6 years of apparent good clinical condition and stability of the implants, the patient came back with a septic state of the hip, and recurrent instability, caused by complete abruption of the cup from acetabulum (Figure 1) Another two stage revision was planned; patient suffered dislocation of the spacer in first hours after intervention and 3 months later was performed second stage revision (stem with modular neck and head, cup with augmentation metal liner). Three days later patient suffered from another dislocation, so implant was further revised (change of modular neck + dual mobility head/cup), and a pelvipodalic cast was even made, considering the poor compliance of the patient,. One month later, due to another local septic state of the hip and in consideration of clinical history, a DAIR procedure was performed with revision of limited modular components until intraoperative stability was assessed (metal spacer + metal liner + dual mobility head and cup). For further assurance, an external fixator was placed around the hip (Figure 2).Purpose
Clinical History
Osteochondral lesions of the knee are relatively common both in young and senior population. The very disabling clinical symptoms, in association to the scarce regenerative capacity of the articular cartilage and the increased risk of developing a secondary osteoarthritis make an effective treatment mandatory. From December 2008 to January 2013, 34 patients (35 knees), 24 males and 10 females (mean age 36.2 years range 14–66) underwent implant of Maioregen® (Finceramica Faenza S.P.A, Italy) biomimetic tri-layer osteochondral scaffold. In 17 cases the osteochondral lesion was cause by an osteochondritis dissecans (acute or sequela), in 13 cases by a spontaneous osteonecrosis and in 4 cases the etiology was traumatic. Patients were evaluated with subjective IKDC and Tegner Lysholm scores, VAS and Tegner Activity Scale before surgery and at regular follow up (mean follow up 38.4 months, range 13 months max 63 months).Purpose
Methods and Materials
Osteochondral lesions of the knee are relatively common both in young and senior population. The very disabling clinical symptoms, in association to the scarce regenerative capacity of the articular cartilage and the increased risk of developing a secondary osteoarthritis make an effective treatment mandatory. From December 2008 to January 2013, 34 patients (35 knees), 24 males and 10 females (mean age 36.2 years range 14–66) underwent implant of Maioregen® (Finceramica Faenza S.P.A, Italy) biomimetic osteochondral scaffold. In 17 cases the osteochondral lesion was cause by an osteochondritis dissecans (acute or sequela), in 13 cases by a spontaneous osteonecrosis and in 4 cases the etiology was traumatic. Patients were evaluated with subjective IKDC and Tegner Lysholm scores, VAS and Tegner Activity Scale before surgery and at regular follow up (mean follow up 38.4 months, range 13 months max 63 months).INTRODUCTION
MATERIALS AND METHODS
